Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 897 | 1,380 | 7,788 | 3,880 | 15,685 |
| Gross Profit | 897 | 1,380 | 7,788 | 3,880 | 15,685 |
| Operating Expenses | 4,153 | 3,577 | 6,979 | 7,066 | 4,458 |
| Operating Income | -3,256 | -2,197 | 809 | -3,186 | 11,227 |
| Other Income | 42 | 69 | 101 | 154 | 225 |
| Pre-tax Income | -3,214 | -2,128 | 910 | -3,032 | 11,452 |
| Income Tax | 3,306 | -851 | 3,903 | -6,180 | 4,582 |
| Net Income Continuous | -6,520 | -1,277 | -2,993 | 3,148 | 6,870 |
| Net Income | $-6,520 | $-1,277 | $-2,993 | $3,148 | $6,870 |
| EPS Basic Total Ops | -0.70 | -0.15 | -0.30 | 0.35 | 0.75 |
| EPS Basic Continuous Ops | -0.71 | -0.14 | -0.33 | 0.34 | 0.75 |
| EPS Diluted Total Ops | -0.70 | -0.15 | -0.25 | 0.30 | 0.65 |
| EPS Diluted Continuous Ops | -0.71 | -0.14 | -0.28 | 0.32 | 0.67 |
| EBITDA(a) | $-3,224 | $-2,165 | $844 | $-3,150 | $11,257 |